A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer

NCT03327064 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped COVID-19 pandemic, unable to enroll participants

Conditions

Non-melanoma Skin Cancer

Interventions

DRUG: UAB30
DRUG: Placebo

Sponsor

University of Alabama at Birmingham